Turing Pharmaceuticals, from which co-founder Martin Shkreli resigned a day after being indicted on fraud charges unrelated to the price-gouging that made him famous, announced Tuesday that it will “streamline its operations” through a “reduction of workforce.” Merry Christmas!

Interim CEO Ron Tilles would not say how many people were getting laid off or when. The cutbacks, he told the New York Daily News, will “put us in the best position to continue executing on our long-term plan.”

“Though this has been a period of leadership transition for Turing,” Tilles said, “I am confident that the fundamental business model remains strong.” Ho ho ho!

Photo via AP Images. Contact the author of this post: brendan.oconnor@gawker.com.